Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Ambalal Sarabhai Enterprises

Sector: Healthcare | Industry: Drugs & Pharma
R 9.47 -0.59  | -5.86% -15.90% 15.69 72.57
BSE Price: Oct 15, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 15, 2019 9.47 -0.59 -5.86% 9.98 10.06 11,176 9.22 - 9.98
NSE Jan 18, 2002 4.25 -0.35 -7.61% 4.40 4.60 540 4.25 - 4.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 9,589 P/B: 2.36 NSE Code: AMBASARABH
52-Week Range: R 9.04 - 16.45 Dividend Yield: 0.00% BSE Code: 500009
TTM EPS: R 0.60 Book Value: R 4.02 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Ambalal Sarabhai Enterprises -28.47 -17.00 -24.78 -15.90 6.04 14.49 -2.48
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 21.50 4.79 7.73
Net Profit 84.65 -65.35 15.99
EPS 232.63 -55.47 17.19
Book Value 15.48 -7.53 74.48
Average
Operating Margin 7.48 4.83 16.77
Net Margin 1.27 -3.74 1.03
Return on Networth 7.01 -15.57 56.31
Return on Investment 13.17 5.86 26.96
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -30.89 -14.04 -30.89
Operating Profit -65.78 14.24 -65.78
Net Profit -81.71 158.10 -81.71
EPS -48.62 169.07 -48.62
TTM
Revenue -3.33 11.01 -3.33
Operating Profit 1.75 -21.39 1.75
Net Profit 25.84 -22.45 25.84
EPS 8.88 5.71 8.88
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Ambalal Sarabhai Enterprises 72.57 146.83 2.52 1.64 7.01 2.36 15.69
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Fund Houses invested in the stock
Fund Mar-00 Dec-99 Dec-99 Dec-99 Dec-99
Nippon India Mutual Fund 0.098 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Ambalal Sarabhai Enterprises Ltd.

Address: Shanti Sadan, Mirzapur Road, Ahmedabad, Gujarat - 380001

Email: [email protected]

Website: www.sarabhai.co.in

Registrar & Transfer Agent: MCS Share Transfer Agent Limited

Address: 10, Aram Apartment, 12, Sampatrao Colony,B/h. Laxmi Hall, Alkapuri, Vadodara - 390 007., 10, Aram Apartment, 12, Sampatrao Colony, B/h. Laxmi Hall, Alkapuri

Essential checks
Altman Z-Score
0.46
Piotroski F-Score
7
Modified C-Score
2
3-Years Price to Earnings
15.69
3-Years Price to Book
2.36
Earnings Yield
EBIT / Enterprise value
10.51%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59